Vaishali Pharma Ltd - VAISHALI PHARMA Share Price

Sector: Trading | ISIN: INE972X01014
₹ 153.30 (-0.39%) icon4 Mar, 2024, 1:18:21 PM
Open
₹ 153.90
Prev. Close
₹ 153.90
Turnover(lac)
₹ 0.00
Day's High
₹ 157.80
Day's Low
₹ 152.45
52 Wk High
₹ 203.60
52 Wk Low
₹ 114.85
Book Value
₹ 43.53
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 164.33
P/E
28.24
EPS
5.45
Div. Yield
0.00

Vaishali Pharma Ltd KEY RATIOS

sector: Trading

  • CMP

    as on 3/4/2024 1:18:21 PM

    ₹ 153.3 -0.60 -0.39
  • Open
  • ₹ 153.9
  • Prev. Close
  • ₹ 153.9
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 157.8
  • Day's Low
  • ₹ 152.45
  • 52 Week's High
  • ₹ 203.6
  • 52 Week's Low
  • ₹ 114.85
  • Book Value
  • ₹ 43.53
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 164.33
  • P/E
  • 28.24
  • EPS
  • 5.45
  • Divi. Yield
  • 0

Vaishali Pharma Ltd Corporate Actions

25 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2024

12:00 AM

02 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Nov , 2023

12:00 AM

05 Sep , 2023

12:00 AM

AGM

Announcement date: 05 Sep , 2023

View Details

05 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jul , 2023

12:00 AM

15 May , 2023

12:00 AM

15 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Sep , 2023

12:00 AM

BookCloser

View Details

Vaishali Pharma Ltd News and Update

Image not found
  • 3 hours ago |
  • 12:22 AM

The project is set for commissioning within 18 months from the date of signing the power purchase agreement

Article Image
Image not found
  • IIFL News Service |
  • 01 March, 2024 |
  • 12:17 AM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Vaishali Pharma Ltd SHAREHOLDING SNAPSHOT
04 March , 2024 | 01:38 PM

PROMOTER - TOTAL26.62%

Indian: 26.62%

Foreign: 0%

NON-PROMOTER - TOTAL 73.38%

Institutions: 0.00%

Non-Institutions: 73.38%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Vaishali Pharma Ltd FINANCIALS

No Data Available To Display Chart

Vaishali Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Vaishali Pharma Ltd

  • Atul Vasani
  • Chairman & Managing Director
  • Jagruti Vasani
  • Whole-time Director
  • Dewansh Vasani
  • Executive Director
  • Ashvin Jamnadas Ganatra
  • Independent Director
  • Manish Bhagwandas Ved
  • Independent Director
  • Vishwa Mekhia
  • Company Sec. & Compli. Officer
  • Pratik Vikram Jakhelia
  • Independent Director

Summary

Vaishali Pharma Limited was originally incorporated as a private limited company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the company acquired the business of proprietorship concerns of its promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently business of this proprietorship firm was merged into Vaishali Pharma Private Limited. Subsequently the company was converted into a public limited company and the name of the company was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the promoters of the company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, the company has applied for 186 registrations in 13 countries for some of its product, out of which it has successfully received 71 approvals from 7 countries and in process of obtaining remaining approvals, which will give boost to export... Read More


Reports by Vaishali Pharma Ltd


Reports by Vaishali Pharma Ltd

Company FAQ

No Record Found